Events Archive

I Am More Than HIV Prevention: Results from the HPTN 091 study with transgender women

HPTN 091, the I Am study, evaluated the impact of a multicomponent HIV prevention strategy to increase the uptake and adherence of pre-exposure prophylaxis (PrEP) among transgender women. The strategy included HIV prevention services, gender-affirming hormone therapy, and peer health navigation. This webinar will feature Dr. Tonia Poteat, Ph.D., Duke University School of Nursing, Division…

Update on Injectable Lenacapavir for PrEP

Please join AVAC for updates on the PURPOSE trials for injectable lenacapavir for PrEP. Gilead will provide an overview of the PURPOSE 1 and 2 trial results as well as insight into the status of PURPOSE 3, 4, and 5.

True Choice in HIV Prevention Involves More than Product Options: Novel strategies in service delivery

Video Recording and English Audio / Portuguese Audio / Spanish Audio / Ukrainian Audio / Slides / Resources Join The Choice Agenda and presenters from Brazil, Kenya, and South Africa to discuss novel strategies for the delivery of HIV prevention interventions. All HIV prevention products have their “Achilles Heels.” Differentiated service delivery supports reaching a…

Building a Comprehensive Approach to HIV Prevention: Strengthening Gender-Based Violence Response in PrEP Services

Slides / Recording Experiencing gender-based violence (GBV) hinders access to and effective use of HIV prevention products by those who would benefit most from them, especially adolescent girls and young women. While the introduction of new PrEP products is an exciting development for HIV prevention programs worldwide, optimizing the impact of PrEP choice requires understanding…

Launch of the PrEP Ring Early Market Access Vehicle (EMAV)

Slides / Recording This virtual event will launch the PrEP Ring Early Market Access Vehicle (EMAV), recently announced by CIFF in partnership with the Global Fund. This initiative will provide up to $2 million USD to purchase up to 150,000 dapivirine vaginal rings in countries implementing Global Fund HIV grants. More information is available in…

Integrating HIV Prevention and PrEP Services in U.S. Correctional Settings

Recording / Slides / Resources This webinar, presented by The Choice Agenda, will explore the integration of HIV prevention and PrEP services in diverse U.S. correctional settings and during the critical period following release. It will also highlight innovative HIV status-neutral approaches, fostering holistic and comprehensive HIV care, treatment, and prevention services in these settings.…

PEP: The Forgotten HIV Prevention

This webinar, hosted by the South to South Learning Network, will explore the latest updates to post-exposure prophylaxis (PEP) guidelines, review the outcomes of a recent PEP meeting that included five countries, and discuss how the updated PEP guidelines can be applied in practice. Participants will learn from country experiences with integrating PEP and PrEP,…

Center for Biomedical Research Seminar: Dapivirine Vaginal Ring – The 3-month Ring and Other Updates

Please join the Center for Biomedical Research for their next seminar series presentation, “Dapivirine Vaginal Ring – The 3-month Ring and Other Updates,” presented by Jeremy Nuttall, Barbara Friedland, and Diantha Pillay. Jeremy Nuttall is Senior Director of Preclinical Sciences for the Population Council, where he is responsible for determining preclinical testing strategy. Barbara Friedland…

Do Vaginas Demand Perfection? Implications for Event-Driven PrEP

Recording / Slides Dr. Jenell Stewart (University of Minnesota, Hennepin Healthcare) joins The Choice Agenda to discuss and analyze recent research on HIV PrEP and implications for event driven PrEP across sex and gender.

WHO Global PrEP Network – Destination Prevention: New Guidance for PrEP and PEP

This 90-minute webinar is intended for communities, providers, policy makers and advocates for PrEP, PEP and HIV prevention. We will provide an overview of the key takeaways and new guidance from newly released WHO PrEP Implementation Tool: Provider Module for Oral and Long Acting PrEP and the 2024 Guidelines on HIV Post-Exposure Prophylaxis. We will…